iRhythm Technologies (IRTC)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of iRhythm Technologies (IRTC)
iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio includes ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for several days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.
Key Insights
Critical company metrics and information
Share Price
$85.18Market Cap
$2.67 BillionTotal Outstanding Shares
31.30 Million SharesTotal Employees
2,000Dividend
No dividendIPO Date
October 20, 2016SIC Description
Surgical & Medical Instruments & ApparatusHomepage
https://www.irhythmtech.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow From Financing Activities, Continuing | $511.86 Million |
Net Cash Flow From Operating Activities, Continuing | $-31.81 Million |
Net Cash Flow From Investing Activities, Continuing | $576000.00 |
Net Cash Flow, Continuing | $480.62 Million |
Net Cash Flow | $480.62 Million |
Net Cash Flow From Operating Activities | $-31.81 Million |
Net Cash Flow From Financing Activities | $511.86 Million |
Net Cash Flow From Investing Activities | $576000.00 |
Income Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Cost Of Revenue | $180.14 Million |
Basic Average Shares | $93.50 Million |
Depreciation and Amortization | $20.34 Million |
Selling, General, and Administrative Expenses | $418.91 Million |
Income Tax Expense/Benefit | $669000.00 |
Revenues | $560.02 Million |
Net Income/Loss | $-150.66 Million |
Costs And Expenses | $710.01 Million |
Net Income/Loss Available To Common Stockholders, Basic | $-150.66 Million |
Benefits Costs and Expenses | $710.01 Million |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Gross Profit | $379.89 Million |
Income/Loss From Continuing Operations Before Tax | $-149.99 Million |
Operating Income/Loss | $-150.60 Million |
Operating Expenses | $530.49 Million |
Diluted Earnings Per Share | $4.86 |
Diluted Average Shares | $93.50 Million |
Basic Earnings Per Share | $4.86 |
Income/Loss From Continuing Operations After Tax | $-150.66 Million |
Net Income/Loss Attributable To Parent | $-150.66 Million |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Balance Sheet
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Accounts Payable | $7.59 Million |
Equity | $71.77 Million |
Cash | $165.46 Million |
Fixed Assets | $122.39 Million |
Inventory | $15.03 Million |
Liabilities And Equity | $909.69 Million |
Noncurrent Liabilities | $737.82 Million |
Current Liabilities | $100.10 Million |
Equity Attributable To Parent | $71.77 Million |
Noncurrent Assets | $281.78 Million |
Equity Attributable To Noncontrolling Interest | $0.00 |
Other Current Liabilities | $92.51 Million |
Current Assets | $627.91 Million |
Other Current Assets | $447.41 Million |
Assets | $909.69 Million |
Other Non-current Assets | $159.39 Million |
Liabilities | $837.92 Million |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.